Boston Common Asset Management, LLC - Novozymes A/S ownership

Novozymes A/S's ticker is NVZMY and the CUSIP is 670108109. A total of 15 filers reported holding Novozymes A/S in Q2 2017. The put-call ratio across all filers is - and the average weighting 0.2%.

Quarter-by-quarter ownership
Boston Common Asset Management, LLC ownership history of Novozymes A/S
ValueSharesWeighting
Q3 2023$756
-12.3%
18,693
+1.0%
0.02%0.0%
Q2 2023$862
-10.1%
18,500
-1.3%
0.02%
-10.0%
Q1 2023$959
+3.1%
18,745
+1.8%
0.02%
-54.5%
Q4 2022$930
-99.9%
18,413
+5.7%
0.04%
-4.3%
Q3 2022$879,000
-18.8%
17,415
-3.7%
0.05%
-14.8%
Q2 2022$1,083,000
+68.2%
18,087
+94.4%
0.05%
+92.9%
Q1 2022$644,000
-24.4%
9,303
-10.3%
0.03%
-17.6%
Q4 2021$852,000
+27.5%
10,371
+6.4%
0.03%
+17.2%
Q3 2021$668,000
-3.3%
9,747
+6.3%
0.03%
-3.3%
Q2 2021$691,000
+37.6%
9,167
+17.4%
0.03%
-6.2%
Q1 2021$502,000
+75.5%
7,811
+57.2%
0.03%
+60.0%
Q4 2020$286,000
+7.9%
4,970
+18.2%
0.02%
-20.0%
Q3 2020$265,000
+8.2%
4,205
-1.0%
0.02%
-3.8%
Q2 2020$245,000
-72.7%
4,247
-80.1%
0.03%
-76.6%
Q3 2019$897,000
-21.9%
21,334
-13.2%
0.11%
-22.4%
Q2 2019$1,148,000
-4.7%
24,577
-6.1%
0.14%
-8.3%
Q1 2019$1,205,000
+19.8%
26,185
+16.0%
0.16%
+6.1%
Q4 2018$1,006,000
-1.9%
22,567
+21.0%
0.15%
+15.7%
Q3 2018$1,025,000
+14.5%
18,656
+5.7%
0.13%
+14.4%
Q2 2018$895,000
-22.0%
17,642
-20.8%
0.11%
-17.8%
Q1 2018$1,148,000
-0.3%
22,282
+10.6%
0.14%
-1.5%
Q4 2017$1,152,000
+0.7%
20,143
-9.6%
0.14%
-4.2%
Q3 2017$1,144,000
+17.3%
22,294
-0.0%
0.14%
+11.7%
Q2 2017$975,000
+10.5%
22,303
+0.5%
0.13%
+6.7%
Q1 2017$882,000
+18.7%
22,193
+3.1%
0.12%
+11.1%
Q4 2016$743,000
+2.8%
21,518
+30.9%
0.11%
+176.9%
Q3 2016$723,000
+12.1%
16,441
+21.6%
0.04%
+5.4%
Q2 2016$645,000
+8.0%
13,523
+1.9%
0.04%
+8.8%
Q1 2016$597,00013,2680.03%
Other shareholders
Novozymes A/S shareholders Q2 2017
NameSharesValueWeighting ↓
ZEVIN ASSET MANAGEMENT LLC 53,160$3,191,0000.72%
Boston Common Asset Management, LLC 18,087$1,083,0000.05%
ST GERMAIN D J CO INC 5,000$300,0000.02%
Private Capital Group, LLC 395$24,0000.02%
CAPTRUST FINANCIAL ADVISORS 3,579$215,0000.00%
MAR VISTA INVESTMENT PARTNERS LLC 273$16,0000.00%
Financial Avengers, Inc. 10$1,0000.00%
PNC FINANCIAL SERVICES GROUP, INC. 3,830$229,0000.00%
View complete list of Novozymes A/S shareholders